Solid lipid nanoparticles: a promising tool for insulin delivery

References

• Novak M, Mucsi I, Rhee CM, et al. Increased risk of incident chronic kidney disease, cardiovascular disease, and mortality in patients with diabetes with comorbid depression. Diabetes Care. 2016;39(11):1940–1947.
   PubMed Web of Science ®Google Scholar
• Wild SH, Walker JJ, Morling JR, et al. Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care. 2018;41(2):341–347.
   PubMed Web of Science ®Google Scholar
• Rice D, Kocurek B, Snead CA. Chronic disease management for diabetes: baylor health care system’s coordinated efforts and the opening of the diabetes health and wellness institute. Proc (Bayl Univ Med Cent). 2010;23(3):230–234.
   PubMedGoogle Scholar
• Madhav M. Long-awaited dream of oral insulin: where did we reach. Asian J Pharm Clin Res. 2011;4(2):15–20.
   Google Scholar
• Chin RL, Martinez R, Garmel G. Gas gangrene from subcutaneous insulin administration. Am J Emerg Med. 1993;11(6):622–625.
   PubMed Web of Science ®Google Scholar
• Rossetti P, Porcellati F, Bolli GB, et al. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs. Diabetes Care. 2008;31(Supplement 2):S113–S120.
   PubMedGoogle Scholar
• Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017 Mar 30 2017;3(1):17016.
   PubMedGoogle Scholar
• DiSanto RM, Subramanian V, Gu Z. Recent advances in nanotechnology for diabetes treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Jul-Aug;7(4):548–564.
   PubMed Web of Science ®Google Scholar
• Mansoor S, Kondiah PPD, Choonara YE, et al. Polymer-based nanoparticle strategies for insulin delivery. Polymers (Basel). 2019;11(9):1380.
   PubMed Web of Science ®Google Scholar
• Whittam AJ, Maan ZN, Duscher D, et al. Challenges and opportunities in drug delivery for wound healing. Adv Wound Care. 2016;5(2):79–88.
   Web of Science ®Google Scholar
• Ansari MJ, Anwer MK, Jamil S, et al. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats. Drug Deliv. 2016;23(6):1972–1979. 2016 July 23.
   PubMed Web of Science ®Google Scholar
• Sharma G, Wilson K, van der Walle CF, et al. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm. 2010 Oct;76(2):159–169.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus. Int J Pharm. 2018 Oct 5 2018;549(1–2):201–217.
   PubMed Web of Science ®Google Scholar
• Yu J, Wang Q, Liu H, et al. Glucose-responsive microspheres as a smart drug delivery system for controlled release of insulin. Eur J Drug Metab Pharmacokinet. 2020 [2020 February 1];45(1):113–121.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang W, Li H, et al. Microspheres for the oral delivery of insulin: preparation, evaluation and hypoglycaemic effect in streptozotocin-induced diabetic rats. Drug Dev Ind Pharm. 2018 Jan;44(1):109–115.
   PubMed Web of Science ®Google Scholar
• Fonte P, Araújo F, Silva C, et al. Polymer-based nanoparticles for oral insulin delivery: revisited approaches. Biotechnol Adv. 2015;33(6, Part 3):1342–1354.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang Y, Liu C-G. Polymeric nanoparticles based on carboxymethyl chitosan in combination with painless microneedle therapy systems for enhancing transdermal insulin delivery. RSC Adv.[10.1039/D0RA04460A] 2020;10(41):24319–24329.
   PubMed Web of Science ®Google Scholar
• Scioli Montoto S, Muraca G, Ruiz ME. Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects [Review]. Front Mol Biosci. 2020 [2020-October-30]; 7(319). doi: 10.3389/fmolb.2020.587997
   PubMedGoogle Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 2000 Jul;50(1):161–177.
   PubMed Web of Science ®Google Scholar
• Plapied L, Duhem N, Des Rieux A, et al. Fate of polymeric nanocarriers for oral drug delivery. Curr Opin Colloid Interface Sci. 2011 June 1;16(3):228–237.
   Web of Science ®Google Scholar
• Kim H, Park H, Lee SJ. Effective method for drug injection into subcutaneous tissue.Sci Rep. 2017 [2017 August 29];7(1):9613.
   PubMedGoogle Scholar
• Bahman F, Greish K, Taurin S. Nanotechnology in insulin delivery for management of diabetes. Pharm Nanotechnol. 2019;7(2):113–128.
   PubMedGoogle Scholar
• Hermansen K, Rönnemaa T, Petersen A, et al. Intensive therapy with inhaled insulin via the AERx insulin diabetes management system. Diabetes Care. 2004 February 01;27(1):162–167.
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Fisher L, Guzman S, et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005 Oct;28(10):2543–2545.
   PubMed Web of Science ®Google Scholar
• Edelman S, Pettus J. Challenges associated with insulin therapy in type 2 diabetes mellitus. Am J Med. 2014 Oct;127(10):S11–6.
   PubMed Web of Science ®Google Scholar
• Shah RB, Patel M, Maahs DM, et al. Insulin delivery methods: past, present and future. Int J Pharm Investig. 2016 Jan-Mar;6(1):1–9.
   PubMed Web of Science ®Google Scholar
• Kalra S, Gupta Y. Clinical applications of intramuscular insulin. Journal of Endocrinology and Metabolism. December 18 2014;9:10
   Google Scholar
• Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016 September 1;91(9):1231–1255. DOI: 10.1016/j.mayocp.2016.06.010.
   PubMed Web of Science ®Google Scholar
• Alsulays BB, Anwer MK, Soliman GA, et al. Impact of penetratin stereochemistry on the oral bioavailability of insulin-loaded solid lipid nanoparticles. Int J Nanomedicine. 2019;14:9127–9138.
   PubMed Web of Science ®Google Scholar
• Madkhali OA. Perspectives and prospective on solid lipid nanoparticles as drug delivery systems. Molecules. 2022 Feb 24 2022;27(5):1543.
   PubMed Web of Science ®Google Scholar
• Borges A, Freitas V, Mateus N, et al. Solid lipid nanoparticles as carriers of natural phenolic compounds. Antioxidants (Basel). 2020 Oct 15. 2020;9(10). doi: 10.3390/antiox9100998.
   PubMedGoogle Scholar
• Basha SK, Dhandayuthabani R, Muzammil MS, et al. Solid lipid nanoparticles for oral drug delivery materialstoday: proceedings. 2021 January 1;36:313–324. doi:10.1016/j.matpr.2020.04.109.
   Google Scholar
• Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine. 2007;2(3):289–300.
   PubMed Web of Science ®Google Scholar
• Xu L, Wang X, Liu Y, et al. Lipid nanoparticles for drug delivery. Advanced NanoBiomed Research. 2022;2(2):2100109.
   Google Scholar
• Yoon G, Park JW, Yoon I-S. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharm Invest. 2013;43(5):353–362.
   Google Scholar
• Makwana V, Jain R, Patel K, et al. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm. 2015;495(1):439–446.
   PubMedGoogle Scholar
• Zhai Y, Zhai G. Advances in lipid-based colloid systems as drug carrier for topic delivery. Journal of Controlled Release. 2014 [2014 November 10];193:90–99.
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, et al. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization [Article]. Int J Pharm. 2007 Aug 1 2007;340(1–2):153–162.
   PubMed Web of Science ®Google Scholar
• Muntoni E, Marini E, Ahmadi N, et al. Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies [Article]. Acta Diabetol. 2019 Dec;56(12):1283–1292.
   PubMed Web of Science ®Google Scholar
• Yang X, Liu Y, Liu C, et al. Biodegradable solid lipid nanoparticle flocculates for pulmonary delivery of insulin [Article]. J Biomed Nanotechnol. 2012 Oct;8(5):834–842.
   PubMed Web of Science ®Google Scholar
• Hecq J, Amighi K, Goole J. Development and evaluation of insulin-loaded cationic solid lipid nanoparticles for oral delivery. J Drug Delivery Sci Technol. 2016;36:192–200. Article. DOI:10.1016/j.jddst.2016.10.012.
   Web of Science ®Google Scholar
• Zimmermann E, Müller RH. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN™) dispersions in artificial gastrointestinal media.Eur J Pharm Biopharm. 2001 [2001 September 1];52(2):203–210.
   PubMed Web of Science ®Google Scholar
• Wang SL, Xie SY, Zhu LY, et al. Effects of poly (lactic-co-glycolic acid) as a co-emulsifier on the preparation and hypoglycaemic activity of insulin-loaded solid lipid nanoparticles. IET Nanobiotechnol. 2009 Dec;3(4):103–108.
   PubMed Web of Science ®Google Scholar
• Xie S, Wang S, Zhao B, et al. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2008;67(2):199–204.
   PubMed Web of Science ®Google Scholar
• Boushra M, Tous S, Fetih G, et al. Methocel-lipid hybrid nanocarrier for efficient oral insulin delivery [Article]. J Pharm Sci. 2016 May;105(5):1733–1740.
   PubMed Web of Science ®Google Scholar
• Yang R, Gao RC, Cai CF, et al. Preparation of gel-core-solid lipid nanoparticle: a novel way to improve the encapsulation of protein and peptide [Article]. Chem Pharm Bull (Tokyo). 2010 Sep;58(9):1195–1202.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Zhang YL, Zhou JP, et al. Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin [Article]. Int J Nanomedicine. 2012;7:3333–3339.
   PubMed Web of Science ®Google Scholar
• He H, Wang P, Cai C, et al. VB12-coated Gel-Core-SLN containing insulin: another way to improve oral absorption [Article]. Int J Pharm. 2015 Sep 30 2015;493(1–2):451–459.
   PubMedGoogle Scholar
• Soares S, Fonte P, Costa A, et al. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles [Article]. Int J Pharm. 2013 Nov 18 2013;456(2):370–381.
   PubMed Web of Science ®Google Scholar
• Battaglia L, Trotta M, Gallarate M, et al. Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: development and influence on insulin stability [Article]. J Microencapsul. 2007 Nov;24(7):660–672.
   PubMed Web of Science ®Google Scholar
• Trotta M, Carlotti ME, Gallarate M, et al. Insulin-loaded SLN prepared with the emulsion dilution technique: in vivo tracking of nanoparticles after oral administration to rats [Article]. J Dispers Sci Technol. 2011;32(7):1041–1045.
   Web of Science ®Google Scholar
• Garcia-Fuentes M, Torres D, Alonso MJ. New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm. 2005;296(1–2):122–132.
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 2007;59(6):478–490.
   PubMed Web of Science ®Google Scholar
• Boushra M, Tous S, Fetih G, et al. Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery [Article]. Int J Pharm. 2016 Sep 10 2016;511(1):462–472.
   PubMedGoogle Scholar
• Gallarate M, Battaglia L, Peira E, et al. Peptide-loaded solid lipid nanoparticles prepared through coacervation technique. Int J Chem Eng. 2011;2011:1–6.
   Google Scholar
• Trotta M, Cavalli R, Carlotti ME, et al. Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique [Article]. Int J Pharm. 2005 Jan 20 2005;288(2):281–288.
   PubMedGoogle Scholar
• Chou LY, Ming K, Chan WC. Strategies for the intracellular delivery of nanoparticles. Chem Soc Rev. 2011 Jan;40(1):233–245.
   PubMed Web of Science ®Google Scholar
• Gaspar DP, Almeida AJ. Surface-Functionalized Lipid Nanoparticles for Site-Specific Drug Delivery. In: Pathak Y, editor. Surface Modification of Nanoparticles for Targeted Drug Delivery. 2019. doi:10.1007/978-3-030-06115-9_4. Springer, Cham.
   Google Scholar
• Mout R, Moyano DF, Rana S, et al. Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev. 2012 Apr 7 2012;41(7):2539–2544.
   PubMed Web of Science ®Google Scholar
• Gaspar PD, Faria V, Quintas PJ, et al. Targeted delivery of lipid nanoparticles by means of surface chemical modification. Curr Org Chem. 2017;21(23):2360–2375.
   Web of Science ®Google Scholar
• Boushra M, Tous S, Fetih G, et al. Development of bi-polymer lipid hybrid nanocarrier (BLN) to improve the entrapment and stability of insulin for efficient oral delivery. J Drug Delivery Sci Technol. 2019 Article;49:632–641. DOI:10.1016/j.jddst.2019.01.007.
   Web of Science ®Google Scholar
• Sgorla D, Lechanteur A, Almeida A, et al. Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery. Expert Opin Drug Deliv. 2018 Mar;15(3):213–222.
   PubMed Web of Science ®Google Scholar
• FZhang Z, Lv H, Zhou J. Novel solid lipid nanoparticles as carriers for oral administration of insulin [Article]. Pharmazie. 2009;64(9):574–578.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping Q, Huang G, et al. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin [Article]. Int J Pharm. 2006 Dec 11 2006;327(1–2):153–159.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping Q, Huang G, et al. Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model. J Nanosci Nanotechnol. 2006;6(9–10):2959–2966.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Mazzaglia D, Bonferoni MC, et al. Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system [Article]. Carbohydr Polym. 2011;84(3):919–925.
   Web of Science ®Google Scholar
• Teixeira J, Gehm C, Júlio A, et al., editors. Chitosan as mucoadhesive agent to enhance absorption of therapeutic proteins encapsulated into solid lipid nanoparticles. TechConnect Briefs. 2009;2:111–114 .
   Google Scholar
• Xu Y, Zheng Y, Wu L, et al. Novel solid lipid nanoparticle with endosomal escape function for oral delivery of insulin [Article]. ACS Appl Mater Interfaces. 2018 Mar 21 2018;10(11):9315–9324.
   PubMed Web of Science ®Google Scholar
• Owens IIIDE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93–102.
   PubMed Web of Science ®Google Scholar
• Yoo MK, Kang SK, Choi JH, et al. Targeted delivery of chitosan nanoparticles to Peyer’s patch using M cell-homing peptide selected by phage display technique. Biomaterials. 2010 Oct;31(30):7738–7747.
   PubMed Web of Science ®Google Scholar
• Anchan R, Koland M. Oral insulin delivery by chitosan coated solid lipid nanoparticles: ex vivo and in vivo studies. J Young Pharm. 2021 March 15;13(1):43–48.
   Web of Science ®Google Scholar
• Beloqui A, Solinís MÁ, Gascón AR, et al. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Control Release. 2013 [2013 March 10];166(2):115–123.
   PubMed Web of Science ®Google Scholar
• Mancini G, Lopes R, Clemente P, et al. Lecithin and parabens play a crucial role in tripalmitin-based lipid nanoparticle stabilization throughout moist heat sterilization and freeze-drying: physical stability of tripalmitin solid lipid nanoparticles. Eur J Lipid Sci Technol. 2015 March 01;117(12):1947–1959.
   Web of Science ®Google Scholar
• CAVALLI R, Bocca C, Miglietta A, et al. Albumin adsorption on stealth and non-stealth solid lipid nanoparticles. STP Pharm Sci. 1999;9(2):183–189.
   Google Scholar
• Schuch A, Deiters P, Henne J, et al. Production of W/O/W (water-in-oil-in-water) multiple emulsions: droplet breakup and release of water. J Colloid Interface Sci. 2013;402:157–164.
   PubMed Web of Science ®Google Scholar
• Yang R, Gao R, Li F, et al. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. Drug Dev Ind Pharm. 2011;37(2):139–148.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Martins S, Ferreira D, et al. Oral insulin delivery by means of solid lipid nanoparticles [Article]. Int J Nanomedicine. 2007;2(4):743–749.
   PubMed Web of Science ®Google Scholar
• Severino P, Andreani T, Jäger A, et al. Solid lipid nanoparticles for hydrophilic biotech drugs: optimization and cell viability studies (Caco-2 & HEPG-2 cell lines). Eur J Med Chem. 2014;81:28–34.
   PubMed Web of Science ®Google Scholar
• Gallarate M, Trotta M, Battaglia L, et al. Preparation of solid lipid nanoparticles from W/O/W emulsions: preliminary studies on insulin encapsulation [Article]. J Microencapsul. 2009 Aug;26(5):394–402.
   PubMed Web of Science ®Google Scholar
• Maher S, Ryan B, Duffy A, et al. Formulation strategies to improve oral peptide delivery. Pharm Pat Anal. 2014;3(3):313–336.
   PubMedGoogle Scholar
• Liu J, Gong T, Fu H, et al. Solid lipid nanoparticles for pulmonary delivery of insulin [Article]. Int J Pharm. 2008 May 22 2008;356(1–2):333–344.
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing S. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242(1–2):121–128.
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions.Int J Pharm. 1998 [1998 June 15];168(2):221–229.
   Web of Science ®Google Scholar
• Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles.Int J Pharm. 1996 [1996 March 8];129(1):159–173.
   Google Scholar
• Luzzati V, Tardieu A, Gulik-Krzywicki T. Polymorphism of lipids. Nature. 1968 Mar 16 1968;217(5133):1028–1030.
   PubMed Web of Science ®Google Scholar
• Karn-orachai K, Smith SM, Saesoo S, et al. Surfactant effect on the physicochemical characteristics of γ-oryanol-containing solid lipid nanoparticles. Colloids Surf A Physicochem Eng Asp. 2016 [2016 January 5];488:118–128.
   Web of Science ®Google Scholar
• Kadoya S, Fujii K, K-i I, et al. Freeze-drying of proteins with glass-forming oligosaccharide-derived sugar alcohols. Int J Pharm. 2010 [2010 April 15];389(1):107–113.
   PubMedGoogle Scholar
• Bi R, Shao W, Wang Q, et al. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery [Article]. J Biomed Nanotechnol. 2009 Feb;5(1):84–92.
   PubMed Web of Science ®Google Scholar
• Moslemi P, Najafabadi AR, Tajerzadeh H. A rapid and sensitive method for simultaneous determination of insulin and A21-desamido insulin by high-performance liquid chromatography.J Pharm Biomed Anal. 2003 [2003 September 15];33(1):45–51.
   PubMed Web of Science ®Google Scholar
• Akel H, Csóka I, Ambrus R, et al. In vitro comparative study of solid lipid and PLGA nanoparticles designed to facilitate nose-to-brain delivery of insulin. Int J Mol Sci. 2021;22(24):13258.
   PubMed Web of Science ®Google Scholar
• Zhang L, Song L, Zhang C, et al. Improving intestinal insulin absorption efficiency through coadministration of cell-penetrating peptide and hydroxypropyl-β-cyclodextrin. Carbohydr Polym. 2012;87(2):1822–1827.
   Web of Science ®Google Scholar
• Schilling RJ, Mitra AK. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm Res. 1991;8(6):721–727.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules. 2007;8(10):3054–3060.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Souto EB, Silva AM. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers–a systematic review of in vitro data. Eur J Pharm Biopharm. 2014;87(1):1–18.
   PubMed Web of Science ®Google Scholar
• Naruhashi K, Kurahashi Y, Fujita Y, et al. Comparison of the expression and function of ATP binding cassette transporters in Caco-2 and T84 cells on stimulation by selected endogenous compounds and xenobiotics. Drug Metabolism and Pharmacokinetics. 2011 [2011 January 1];26(2):145–153.
   PubMed Web of Science ®Google Scholar
• Rand MD, Montgomery SL, Prince L, et al. Developmental toxicity assays using the Drosophila model. Curr Protoc Toxicol. 2014;59(1):1.12. 1–1.12. 20.
   PubMedGoogle Scholar
• Fangueiro JF, Gonzalez-Mira E, Martins-Lopes P, et al. A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing [Article]. Pharm Dev Technol. 2013 May-Jun;18(3):545–549.
   PubMed Web of Science ®Google Scholar
• Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018;133:285–308.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Zafar N, Fessi H, et al. Double emulsion solvent evaporation techniques used for drug encapsulation. Int J Pharm. 2015 [2015 December 30];496(2):173–190.
   PubMed Web of Science ®Google Scholar
• Hao J, Wang F, Wang X, et al. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur J Pharm Sci. 2012 Sep 29 2012;47(2):497–505.
   PubMed Web of Science ®Google Scholar
• Fonte P, Nogueira T, Gehm C, et al. Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin [Article]. Drug Deliv Transl Res. 2011 Aug;1(4):299–308.
   PubMed Web of Science ®Google Scholar
• Ruenraroengsak P, Cook JM, Florence AT. Nanosystem drug targeting: facing up to complex realities. J Control Release. 2010 Feb 15 2010;141(3):265–276.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009 Jul;71(4):349–358.
   PubMed Web of Science ®Google Scholar
• Dumont C, Bourgeois S, Fessi H, et al. Lipid-based nanosuspensions for oral delivery of peptides, a critical review. International Journal of Pharmaceutics. 2018 April;541(1–2):117–135.
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, et al. Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release. 2006;114(2):242–250.
   PubMed Web of Science ®Google Scholar
• Garcia-Fuentes M, Prego C, Torres D, et al. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly (ethylene glycol) as carriers for oral calcitonin delivery. Eur J Pharm Sci. 2005;25(1):133–143.
   PubMed Web of Science ®Google Scholar
• Des Rieux A, Fievez V, Garinot M, et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1–27.
   PubMed Web of Science ®Google Scholar
• Khafagy E-S, Morishita M, Kamei N, et al. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins. Int J Pharm. 2009;381(1):49–55.
   PubMedGoogle Scholar
• Yadav P, Yadav A. Preparation and optimization of insulin loaded solid lipid nanoparticles for the targeted delivery of insulin to the Lungs for Diabetes Treatment via Inhalation. 2021.
   Google Scholar
• Arduino I, Liu Z, Rahikkala A, et al. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique. Acta Biomater. 2021 Feb;121:566–578.
   PubMed Web of Science ®Google Scholar
• Chiesa E, Dorati R, Pisani S, et al. The microfluidic technique and the manufacturing of polysaccharide nanoparticles. Pharmaceutics. 2018 Dec 9 2018;10(4):267.
   PubMed Web of Science ®Google Scholar
• Jaradat E, Weaver E, Meziane A, et al. Microfluidics technology for the design and formulation of nanomedicines. Nanomaterials (Basel). 2021 Dec 18 2021;11(12):3440.
   PubMedGoogle Scholar